Episodes

  • ACT Brief: SCOPE Highlights Operational Discipline, AI Adoption Accelerates Execution, and FDA Rethinks Evidence Standards

    ACT Brief: SCOPE Highlights Operational Discipline, AI Adoption Accelerates Execution, and FDA Rethinks Evidence Standards
    Feb 20 2026
    In today’s ACT Brief, we examine how SCOPE 2026 reinforced the link between speed and strategy, how AI adoption is driving real-world efficiency gains, and how FDA’s evolving evidence standards could reshape approval pathways.
    Show More Show Less
    2 mins
  • ACT Brief: Predictive Analytics Advance, Collaborative Data Standards Scale, and Moderna’s Flu Vaccine Review Moves Forward

    ACT Brief: Predictive Analytics Advance, Collaborative Data Standards Scale, and Moderna’s Flu Vaccine Review Moves Forward
    Feb 19 2026
    In today’s ACT Brief, we examine how predictive analytics are shaping portfolio decisions, how industry collaboration is scaling digital data standards, and how FDA review of an mRNA flu vaccine candidate is back on track.
    Show More Show Less
    2 mins
  • ACT Brief: AI Enables Real-Time Trial Oversight, Provider Engagement Strengthens Recruitment, and HHS Leadership Restructures Operations

    ACT Brief: AI Enables Real-Time Trial Oversight, Provider Engagement Strengthens Recruitment, and HHS Leadership Restructures Operations
    Feb 18 2026
    In today’s ACT Brief, we examine how AI is enabling continuous trial monitoring and faster site decisions, how provider participation influences recruitment in pragmatic trials, and how leadership restructuring at HHS may shape health policy execution.
    Show More Show Less
    2 mins
  • ACT Brief: AI Moves Into Implementation, Digital Measurement Adoption Accelerates, and Global Trial Competition Intensifies

    ACT Brief: AI Moves Into Implementation, Digital Measurement Adoption Accelerates, and Global Trial Competition Intensifies
    Feb 17 2026
    In today’s ACT Brief, we examine how AI is shifting from pilot programs into daily development workflows, how a new adoption platform is helping sponsors integrate digital measurement tools, and how global competition and data-driven site selection are reshaping clinical trial activity.
    Show More Show Less
    2 mins
  • ACT Brief: eSource Moves Toward AI-Enabled Validation, Outsourcing Models Shift Toward Flexibility, and Robust Trial Design Becomes Mission Critical

    ACT Brief: eSource Moves Toward AI-Enabled Validation, Outsourcing Models Shift Toward Flexibility, and Robust Trial Design Becomes Mission Critical
    Feb 16 2026
    In today’s ACT Brief, we explore how eSource adoption is advancing with AI-enabled validation and interoperability, examine how flexible outsourcing models are helping sponsors balance control and efficiency, and highlight why adaptive, simulation-driven trial design is becoming essential to improving study success.
    Show More Show Less
    2 mins
  • ACT Brief: Regional Risk Variability Emerges, Patient Experience Drives Retention, and Digital Endpoints Scale in Oncology

    ACT Brief: Regional Risk Variability Emerges, Patient Experience Drives Retention, and Digital Endpoints Scale in Oncology
    Feb 13 2026
    In today’s ACT Brief, we examine new data on regional variation in clinical trial risk, why patient experience must move from intent to execution, and how digital endpoints are advancing efficiency and regulatory alignment in oncology trials.
    Show More Show Less
    2 mins
  • ACT Brief: Real-World Data Connectivity Expands, AI Supports Smarter Data Capture, and Diversity Strategies Refocus at SCOPE

    ACT Brief: Real-World Data Connectivity Expands, AI Supports Smarter Data Capture, and Diversity Strategies Refocus at SCOPE
    Feb 12 2026
    In today’s ACT Brief, we cover a new real-world data collaboration aimed at scalable interoperability, how AI fits into modern data capture and quality oversight, and what leaders say must change to move diversity efforts forward in clinical trials.
    Show More Show Less
    2 mins
  • ACT Brief: AI Scales Trial Design, ESG Becomes a Readiness Test, and Sites Push Back on Payment Practices

    ACT Brief: AI Scales Trial Design, ESG Becomes a Readiness Test, and Sites Push Back on Payment Practices
    Feb 11 2026
    In today’s ACT Brief, we cover how AI is being deployed to optimize global trial design, why ESG performance is emerging as a core vendor qualification signal, and how sites are becoming more selective as payment practices come under scrutiny.
    Show More Show Less
    2 mins